24 September 2015

Important Information
This material is for distribution to Professional Clients (as defined by the FCA Rules) and should not be relied upon by any other persons. Issued by BlackRock Investment Management (UK) Limited, authorised and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL. Tel: 020 7743 3000. Registered in England No. 2020394. For your protection telephone calls are usually recorded. BlackRock is a trading name of BlackRock Investment Management (UK) Limited. This document is for information purposes only and does not constitute an offer or invitation to anyone to invest in any BlackRock funds and has not been prepared in connection with any such offer.

China is a key trading partner for Europe and specific sectors within European-listed equities have significant exposure to growth in the Asia-Pacific region. So where does this summer’s China-inspired volatility leave the outlook for European stocks?

On 11 August 2015, China unexpectedly devalued its currency – a move welcomed by the IMF but met with fears from investors that the Chinese economy was weaker than expected, triggering a global sell-off in equity markets.

China is changing

For European companies – such as those in the consumer staples, metals and miners, and luxury goods sectors – a weaker yuan and a slowing Chinese economy generally means lower demand for their products. That said, some of our senior investors at BlackRock have been on the ground in China, speaking with policy makers, business leaders and clients; the general feeling is that there may have been something of an overreaction to the news coming out of the country. The Chinese economy is shifting away from manufacturing more towards services, therefore focusing on the ‘old’ measures of economic strength (industrials, manufacturing) that many analysts monitor may not be the right lens through which to view China.

Don’t forget Draghi

Chinese policy makers may have dominated the headlines over the summer but we shouldn’t forget just how significant the European Central Bank’s (ECB’s) own monetary policy measures – particularly its quantitative easing (QE) programme – are for European equities. At the ECB meeting earlier this month, ECB President Mario Draghi was surprisingly-focused on recent market volatility and lower demand from emerging markets, emphasising the ECB’s “willingness and ability to act, if warranted, by using all the instruments available within its mandate…the asset purchase programme provides sufficient flexibility in terms of adjusting the size, composition and duration of the programme”. Alongside the announcement that the issue share limit of a country’s debt eligible for purchase as part of the already sizeable QE programme would be increased (up from 25% to 33%), such comments suggest that the ECB will continue to do “whatever it takes” to support the Eurozone economy; that’s good news for European stocks. Though the primary objective of ECB QE is not necessarily to weaken the euro, the increased money supply injected to ward off deflation inevitably drives the currency lower, making exports from the region more competitive.

European recovery intact

While European data has been relatively strong, a slowdown in emerging markets should not be underestimated given that European companies derive 31% of their revenues from emerging markets, of which 6.3% from China. We’ve had an underweight exposure to companies which generate revenues in emerging markets for some time, favouring those companies able to access the domestic European recovery, which remains very much intact despite the recent market volatility. Domestic consumption in Europe looks resilient enough to offset slower growth elsewhere, the credit cycle has picked up (loan growth for both corporates and households looks robust) and there has been a resurgence in earnings.

In this environment, we believe that with fundamental company analysis and a flexible management approach we can navigate the volatile market conditions and capture the best that a recovering Europe has to offer – stock selection is crucial.

CARS ref: RSM-1994

This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or financial product or to adopt any investment strategy. The opinions expressed are as of 21 September 2015 and may change as subsequent conditions vary.

We’ve had an underweight exposure to companies which generate revenues in emerging markets for some time.